Tag : Patient

CCT Impact

Trulieve Expands Patient Access to Medical Cannabis with New Winter Haven Location

CCT IMPACT Agent
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, announced today the opening of a new Florida dispensary, the Company’s 96th nationwide. The new 3,200 sq. ft. dispensary, located in Winter Haven, supports Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable......
CCT Impact

Trulieve Expands Patient Access with Latest Tampa Dispensary

CCT IMPACT Agent
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, announced today the opening of a new Florida dispensary, the Company’s 89th nationwide. The dispensary will be located next to the Citrus Park Town Center and helps meet Trulieve’s goal of ensuring medical......
CCT Impact

Khiron Partners with Colombia Cancer League to Deliver 3,000 Medical Cannabis Patient Consultations

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, today announces, in partnership with the Colombia Cancer League, the launch of the “Cannabis: Medicine for Your Life” campaign throughout Colombia. In partnership with the Colombia Cancer League......
CCT Impact

Cannabis Patient Care™ Named 2021 SIIA Jesse H. Neal Awards Finalist

CCT IMPACT Agent
Cannabis Patient Care™, a leading multimedia platform dedicated to advancing medical research, education, and treatment in the cannabis industry, is proud to announce that publication has been named as a finalist in the Best Subject-Related Package category of the 2021 SIIA Jesse H. Neal Awards. “It is an extraordinary honor that Cannabis Patient Care™ has been......
CCT Impact

Khiron Expands Product Offering in UK and Increases Patient Access

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to provide an operational update with regards to its supply of EU-GMP medical cannabis products to the UK. To help alleviate bottlenecks and stock outs,......
CCT Impact

Vireo Health Opens Two More Green Goods Cannabis Patient Centers in Twin Cities

CCT IMPACT Agent
 Vireo Health of Minnesota, LLC (“Vireo” or “the Company”), a subsidiary of Vireo Health International, Inc. (CNSX: VREO,OTCQX: VREOF), today announced the official openings of two new medical cannabis patient centers located in Burnsville, MN and Woodbury, MN. The new locations officially opened for business on December 31, 2020 and expanded the Green Goods brand to eight total locations in Minnesota. The new......
CCT Impact

Stability Cannabis Announces “StabiliSale” – Oklahoma’s Largest Medical Marijuana Patient Appreciation Sale

CCT IMPACT Agent
Stability Cannabis, who operates one of Oklahoma’s largest medical marijuana dispensaries, announces “StabiliSale” will take place from Saturday December 26th through Thursday December 31st, 2020. Stability Cannabis Dispensary located at 1043 S. Meridian, Oklahoma City, OK 73108. StabiliSale 2020 goes live December 26th through December 31 with savings of up to 75%. Open 24 hours.......
CCT Impact

New Medical Cannabis Patient Center Opens in Blaine, Minnesota

CCT IMPACT Agent
Vireo Health of Minnesota, LLC (“Vireo” or “the Company”), a subsidiary of Vireo Health International, Inc. (CNSX: VREO,OTCQX: VREOF), today announced the official opening of a new medical cannabis patient center in Blaine, Minnesota. The new location, called Green Goods, is the second of four new cannabis patient centers the Company expects to open in Minnesota by......
Market Watch

Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to provide a corporate update on its commercial operations ahead of Q2 earnings which will be announced on August 24th 2020. The update reflects the Company’s revenue......